Mesoblast Ltd (MESO) SEC Filing 20-F Annual report for the fiscal year ending Friday, June 30, 2017

Mesoblast Ltd

CIK: 1345099 Ticker: MESO

View differences made from one year to another to evaluate Mesoblast Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Mesoblast Ltd.


Assess how Mesoblast Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Mesoblast Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: MESO
CIK: 1345099
Form Type: 20-F Annual Report
Accession Number: 0001564590-17-018168
Submitted to the SEC: Wed Aug 30 2017 7:24:42 AM EST
Accepted by the SEC: Wed Aug 30 2017
Period: Friday, June 30, 2017
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: